Aurinia Pharmaceuticals Inc (AUPH)
5.76
-0.01
(-0.17%)
USD |
NASDAQ |
May 17, 16:00
5.74
-0.02
(-0.35%)
Pre-Market: 20:00
Aurinia Pharmaceuticals Shares Outstanding: 143.02M for May 1, 2024
Shares Outstanding Chart
Historical Shares Outstanding Data
| Date | Value |
|---|---|
| May 01, 2024 | 143.02M |
| April 30, 2024 | 142.66M |
| April 26, 2024 | 143.02M |
| April 22, 2024 | 143.70M |
| March 31, 2024 | 143.69M |
| February 14, 2024 | 144.62M |
| December 31, 2023 | 143.83M |
| November 01, 2023 | 143.61M |
| September 30, 2023 | 143.60M |
| August 02, 2023 | 143.42M |
| June 30, 2023 | 143.37M |
| May 03, 2023 | 143.03M |
| April 12, 2023 | 143.03M |
| March 31, 2023 | 143.03M |
| February 27, 2023 | 142.58M |
| December 31, 2022 | 142.27M |
| November 02, 2022 | 142.11M |
| September 30, 2022 | 142.11M |
| August 03, 2022 | 141.89M |
| June 30, 2022 | 141.89M |
| May 09, 2022 | 141.74M |
| April 14, 2022 | 141.74M |
| March 31, 2022 | 141.74M |
| February 25, 2022 | 141.65M |
| December 31, 2021 | 141.60M |
| Date | Value |
|---|---|
| November 02, 2021 | 129.67M |
| September 30, 2021 | 129.57M |
| August 04, 2021 | 128.40M |
| June 30, 2021 | 128.40M |
| May 06, 2021 | 128.16M |
| April 19, 2021 | 128.12M |
| March 31, 2021 | 128.12M |
| February 24, 2021 | 127.45M |
| December 31, 2020 | 126.72M |
| November 05, 2020 | 126.57M |
| September 30, 2020 | 126.45M |
| August 06, 2020 | 126.25M |
| July 27, 2020 | 126.14M |
| July 22, 2020 | 112.81M |
| July 01, 2020 | 112.70M |
| June 30, 2020 | 112.70M |
| June 16, 2020 | 112.63M |
| May 12, 2020 | 112.55M |
| April 20, 2020 | 112.52M |
| April 01, 2020 | 112.49M |
| March 31, 2020 | 112.49M |
| January 01, 2020 | 111.80M |
| December 31, 2019 | 111.80M |
| December 12, 2019 | 109.07M |
| December 09, 2019 | 96.29M |
Shares Outstanding Definition
The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.
Shares Outstanding Range, Past 5 Years
91.79M
Minimum
Jun 30 2019
144.62M
Maximum
Feb 14 2024
126.47M
Average
128.40M
Median
Aug 04 2021
Shares Outstanding Benchmarks
| Acasti Pharma Inc | 9.399M |
| Edesa Biotech Inc | 3.216M |
| Lexaria Bioscience Corp | 12.89M |
| Xenon Pharmaceuticals Inc | 75.47M |
| ESSA Pharma Inc | 44.36M |